Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. (VRDN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · VRDN · as of Jun 9, 2026
Key Statistics
Explore Viridian Therapeutics, Inc. Data
vrdn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 16 · Buy rate: 81.3%
The VRDN analyst consensus is Buy, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month price target is $36.86, representing +134.33% upside from the current price of $15.73.
Competitors & Peers
vrdn competitorsVRDN
CLDX
COGT
EWTX
GLPG
GPCRStock Performance
Full HistoryAbout Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. is a biotechnology firm committed to creating therapies for patients afflicted by serious illnesses. Its primary development efforts include VRDN-001, a humanized monoclona…
what is viridian therapeutics, inc. · vrdn stock overview · viridian therapeutics, inc. company profile · who is viridian therapeutics, inc. ceo · vrdn NASDAQ · viridian therapeutics, inc. headquarters · viridian therapeutics, inc. business segments
About Stock Overview & Key Data
Viridian Therapeutics, Inc. (VRDN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 18, 2014. As of the latest trading session, VRDN stock price is $15.73, with a market capitalization of $1.4B. The stock has returned +5.85% over the past 12 months and -49.45% year-to-date.
According to 16 Wall Street analysts, the consensus rating for Viridian Therapeutics, Inc. stock is Buy, with an average 12-month price target of $36.86. In fiscal year 2025, Viridian Therapeutics, Inc. reported revenue of $70.8M and net income of -$342.6M. For detailed data — including Viridian Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Viridian Therapeutics, Inc. (VRDN) stock price is $15.73. The stock is traded on NASDAQ under the ticker symbol VRDN. The 52-week range is $13.18 – $34.29.